KEY FINDINGS The Asia Pacific regional market for viral vector vaccine manufacturing will have an estimated CAGR of 18.01% during the forecast period of 2019-2027. The Asia-Pacific viral vector vaccine manufacturing market includes countries such as China, India, Japan, Australia, South Korea and Rest of Asia-Pacific.
MARKET INSIGHTS The key drivers for the Asia-Pacific viral vector vaccine manufacturing market are government approvals to conduct trials related to the viral vector vaccines and the rising prevalence of avian influenza in humans.The development of viral vector vaccines would assist in the treatment of avian influenza among the humans, thereby contributing to the growth of the viral vector vaccine manufacturing market in the Asia-Pacific region.
The need for viral vectors may arise for the development of new and advanced vaccines to eliminate infectious and chronic diseases, which will positively influence the growth of the viral vector vaccines manufacturing market in this country.
COMPETITIVE INSIGHTS Prominent market players in the Asia-Pacific regional market for manufacturing viral vector vaccines are Applied Viromics, Batavia Biosciences, Benitec Biopharma, Biogen Idec (Now Biogen Inc.), Biovian, Brammer Bio, Boehringer Ingelheim Gmbh, Cell And Gene Therapy Catapult, Ceva Corporate, Cobra Biologics (Subsidiary Of Recip Ab), Ge Healthcare, Janssen Pharmaceutical Inc., Id Pharma Co. Ltd.,etc.
Companies mentioned 1. ADVANCED BIOTHERAPEUTICS CONSULTING 2. ADVANCED BIOSCIENCE LABORATORIES INC. 3. APPLIED VIROMICS 4. BATAVIA BIOSCIENCES 5. BENITEC BIOPHARMA 6. BIOGEN IDEC (NOW BIOGEN INC.) 7. BIOVIAN 8. BRAMMER BIO 9. BOEHRINGER INGELHEIM GMBH 10. CELL AND GENE THERAPY CATAPULT 11. CEVA CORPORATE 12. COBRA BIOLOGICS (SUBSIDIARY OF RECIP AB) 13. GE HEALTHCARE 14. JANSSEN PHARMACEUTICAL INC. 15. ID PHARMA CO. LTD.
Our reports have been used by over 10K customers, including:
The global recombinant proteins market is projected to reach USD 1.7billion by 2026 from USD 1.0billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industryacademia collaborations,...
Biopharmaceuticals Market Report Overview Biopharmaceuticals market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Biopharmaceuticals market types and applications. It is a focused study on Biopharmaceuticals market space including global...
206 pages •
By The Business Research Company
• Dec 2020
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market. Description: Where is the largest and fastest growing...
The microcarriers market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period. Increasing use of single-use bioreactors for bioprocessing, rising investmnet in R&D for developemnt of vaccines and therapeutic protiens, and increasing government funding for cell and gene therapy. •...
The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research. Many of the current biologics in the pipeline are targeting the indications, which are small-molecule...
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
Biopharmaceuticals Contract Manufacturing Market Report Overview Biopharmaceuticals Contract Manufacturing market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Biopharmaceuticals Contract Manufacturing market types and applications. It is...
Recombinant Protein Market Report Overview Recombinant Protein market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Recombinant Protein market types and applications. It is a focused study on Recombinant Protein market space including global...
The market for cell culture is driven by factors such as rising demand for vaccines, artificial organs and biopharmaceuticals, and growing focus on personalized medicine. Immunization is the most valuable and cost-effective intervention that delivers better health as well as social and economic benefits. Annually, around 2 to 3 million...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
Pharmaceutical
Biopharmaceutical
Protein Therapy
World
Europe
North America
APAC
Gross Domestic Expenditure On R&D
Employment Costs
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.